Chromosome abnormalities in Indonesian patients with short stature by Chrysantine Paramayuda et al.
Paramayuda et al. Molecular Cytogenetics 2012, 5:35
http://www.molecularcytogenetics.org/content/5/1/35CASE REPORT Open AccessChromosome abnormalities in Indonesian
patients with short stature
Chrysantine Paramayuda*, Hannie Kartapradja, Debby D Ambarwati, Helena W Anggaratri, Lita P Suciati,
Nanis S Marzuki and Alida HarahapAbstract
Background: Short stature is associated with several disorders including wide variations of chromosomal disorders
and single gene disorders. The objective of this report is to present the cytogenetic findings in Indonesian patients
with short stature.
Methods: G-banding and interphase/metaphase FISH were performed on short stature patients with and without
other clinical features who were referred by clinicians all over Indonesia to our laboratory during the year
2003–2009.
Results: The results of chromosomal analysis of ninety seven patients (mean age: 10.7 years old) were collected.
The group of patients with other clinical features showed sex chromosome abnormalities in 45% (18/40) and
autosomal abnormalities in 10% (4/40), whereas those with short stature only, 42.1% (24/57) had sex chromosome
abnormalities and 1.75% (1/57) had autosomal abnormalities. The autosomal chromosomal abnormalities involved
mostly subtelomeric regions. Results discrepancies between karyotype and FISH were found in 10 patients,
including detection of low-level monosomy X mosaicism in 6 patients with normal karyotype, and detection of
mosaic aneuploidy chromosome 18 in 1 patient with 45,XX,rob(13;14)(q10;q10).
Statistical analysis showed no significant association between the groups and the type of chromosomal
abnormalities.
Conclusion: Chromosome abnormalities account for about 50% of the short stature patients. Wide variations of
both sex and autosomal chromosomes abnormalities were detected in the study. Since three out of five patients
had autosomal structural abnormalities involving the subtelomeric regions, thus in the future, subtelomeric FISH or
even a more sensitive method such as genomic/SNP microarray is needed to confirm deletions of subtelomeric
regions of chromosome 9, 11 and 18. Low-level mosaicism in normal karyotype patients indicates interphase FISH
need to be routinely carried out in short stature patients as an adjunct to karyotyping.
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Short stature is defined as a standing height below the
3rd percentile for sex according to standard growth chart
[1,2] and is believed to have a strong genetic component.
There are various genetic causes of short stature, which
include chromosomal defects. It has been known that
short stature and poor growth is associated with Turner
syndrome, Down syndrome and other syndromes [2,3].
Therefore, chromosome and molecular analysis are fre-
quently required in short stature cases.* Correspondence: santin@eijkman.go.id
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© 2012 Paramayuda et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumHaploinsufficiency of SHOX gene, which located at
short arm of X chromosome, is reported to be respon-
sible for height deficit in Turner syndrome patients and
other short stature patients, including isolated short
stature without dysmorphic features, Leri-Weill syn-
drome, or Langer syndrome [4]. Furthermore, several
studies also reported autosomal chromosome abnormal-
ities in short stature patients with other clinical features
[5-12] and in those without malformations and minor
anomalies [12,13].
Chromosomal mosaicism has been known to be asso-
ciated with the severity of the patient’s phenotype.
Patients with mosaic 45,X often have milder symptomsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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mosaic 45,X [14] and those with low-level mosaicism
may not always be detected by karyotyping thus pro-
ducing normal karyotyping results. Further analysis on
skin fibroblast was performed by Azcona et al. [15]
and FISH on buccal smear was suggested by Wolff
et al. [16] in Turner syndrome individuals with 46,XX
karyotype to detect 45,X mosaicism. Several studies
performed interphase FISH and metaphase FISH to de-
tect mosaic 45,X in lymphocytes of nonmosaic 45,X
patients [17,18]. Most of previous studies detected
other cell population in nonmosaic 45,X karyotyped
patients and to the best of our knowledge, confirm-
ation of mosaicism in short stature patients with nor-
mal karyotype using FISH technique on uncultured
lymphocytes has not been reported. This study pre-
sents the cytogenetics findings found in Indonesian
patients with short stature. Furthermore, using com-
bination methods of karyotyping and FISH analysis we
also reported result discrepancies that have not been
reported previously.
Results
Ninety seven patients were referred due to short stature
only or short stature with other clinical features such as
dysmorphism, webbed neck, failure to thrive, micro-
cephaly, primary or secondary amenorrhea, cubitus val-
gus, hypospadia and delayed puberty. Among those
patients 88 were females and 9 were males. The age of
the patients varied between 5 days to 26 years of age
(mean age 10.7 years old).
Eighty patients were karyotyped using conventional
G-banding technique, 14 were screened by both karyo-
typing and FISH and 3 were screened by FISH only
due to doctor’s request or the sample did not meet
sampling requirement for karyotyping analysis.
The ninety seven patients were divided into two
groups, which were Group A consisted of those with
other clinical features (40 patients), and Group B those
with short stature only (57 patients).
In Group A, twenty two (55%) out of 40 patients had
chromosomal abnormalities, of which 45% (18/40) showed
sex chromosome abnormalities and 10% (4/40) autosomal
abnormalities. In Group B, twenty five (43.85%) out of 57
patients had chromosomal abnormalities, of which 42.1%
(24/57) had sex chromosome abnormalities and 1.75%
(1/57) had autosomal abnormalities (Table 1).
Among those patients in Group A, 8 patients showed
mosaic 45,X with 46,XX in 2/40 (5%), XY in 1/40 (2.5%),
46,X,i(Xq) in 2/40 (5%), 46,X,del(Xp) in 1/40 (2.5%), 46,
X,r(Y), in 1/40 (2.5%), and 46,X,idic(Y)(pter) in 1/40
(2.5%), whereas among those in Group B, 14 patients
showed mosaic 45,X with 46,XX in 5/57 (8.77%), XY in
1/57 (1.75%), XY/XYY in 1/57 (1.75%), 46,X,i(Xq) in 6/57 (10.53%), 46,X,idic(X)(q23) in 1/57 ( 1.75%). Nonmo-
saic isochromosome Xq (46,X,i(Xq)) was found in 1 pa-
tient in each group. Mosaic 46,X,idic(X),(p22.2) was
found in Group B.
In our study, 14 patients whom were analysed by both
karyotyping and FISH methods showed discrepancies in
10 patients (2 patients from group A and 8 from group B),
of which nine of them showed low-level sex chromosomal
mosaicism and 1 was mosaic chromosome 18 (Table 2).
Autosomal chromosome abnormalities were detected
in five patients, where two of them had mosaic aneu-
ploidy of chromosome 18 (Case no. 05 PB25 and Case
no. 05 PB73), and the other three had mosaic add(18p)
(Figure 1), mosaic ring 9 (Figure 2) and add11q24
(Figure 3) (Table 3). One rob t(13;14) karyotyped pa-
tient (case no. 05 PB25) showed interphase FISH result
of monosomy 18 in 20.7%, trisomy in 18 3.3%, and nor-
mal in 76% (Figure 4). The other patient (Case no
05 PB73) showed monosomy 18 in 12% and normal in
88% (Figure 5). In mosaic add(18p) patient (case no.
05 PB53), 46,XX,add(18p) was found in 16% of cell
population and 46,XX in 84% (Table 3).
Statistical analysis showed no significant association
between the groups and the type of chromosomal abnor-
malities (Figure 6).
Discussion
The genetic background of short stature have been elu-
cidated by many reports and considerable number of
cases can be explained by chromosomal abberations.
The incidence of chromosomal anomalies in short
stature patients was 2.77% (7/253) in males, in females
9.8% (71/719), and in total 8.02% (78/972), which
reported by Moreno-Garcia et al. [19] from a large co-
hort of patients. Different to our study which resulted in
a higher total incidence of 48.45% (47/97) due to selec-
tion of patients. Most literatures reported monosomy X
is the most common chromosome abnormalities asso-
ciated with short stature. Having one X chromosome or
structural abnormalities of sex chromosome involving
the p arm may result in a loss of one copy of SHOX
gene, located on each of the X and Y chromosomes in
the pseudoautosomal region of the short arms [20], and
result in short stature and skeletal abnormalities. Simi-
larly, in our study, this chromosome abberation was
found in both groups, which consisted of non mosaic 45,
X in 22.5% (9/40), mosaic structural and non-structural
in 20% (8/40) and nonmosaic structural 2.5% (1/40) in
group A, whereas group B consisted of 14.03% (8/57)
non mosaic 45,X, 24.56% (14/57) mosaic structural and
non-structural and 3.5% (2/57) nonmosaic structural.
Interestingly, autosomal chromosome abnormalities
were detected also in both groups (10% (4/40) in group
A and 1.75% (1/57) in group B).
Table 1 Summary of chromosome abnormalities in short stature patients with and without other clinical features
based on karyotyping and FISH analysis
Karyotype and FISH results Group A Short stature patients with
other clinical features (no. of cases)
Group B Short stature patients without
other clinical features (no. of cases)
46,XX and/or nuc ish (DXZ1x2) 13 29
46,XY 5 3
Sex chromosomes
nonmosaic monosomy X (45,X) 9 8
46,XX and nuc ish (DXZ1x1)//(DXZ1x2) 2 4
46,XY and/or nuc ish (DXZ1x1)//(DXZ1,DYZ3x1) 1 1
mos 45,X/46,XY and nuc ish
(DXZ1x1)//(DXZ1,DYZ3x1)// (DXZ1,DYZ3x2)
0 1
mos 45,X/46,XX and nuc ish (DXZ1)//(DXZ1x2) 0 1
46,X,i(Xq) 1 1
mos 45,X/46,X,i(Xq) 2 6
46,X,idic(X)(p22.2) * 0 1
mos 45,X/46,X,idic(X)(q23) 0 1
mos 45,X/46,X,del(Xp) 1 0
mos 45,X/46,X,r(Y) 1 0
mos 45,X/46,X,idic(Y)(pter) 1 0
Autosomal chromosome
mosaic aneuploidy chromosome 18** 1 1
mos 46,XX,add(18p)/ 46,XX 1 0
mos 45,XY,-9/46,XY,r(9) 1 0
(p24q34)
46,XY,add(11)(q24) 1 0
*FISH result is shown in Table 2.
**consist of one patient (case no. 05 PB25) with mosaic monosomy 18, trisomy 18 and normal, and one (case no. 05 PB73) with mosaic monosomy 18 and
normal.
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established on cytogenetic grounds for the definition of
low-level mosaicism, but some authors considered the
presence of aneuploid cells of 6-10% as being low-level
mosaicism [21] and <6% by others [22,23]. Our study
also showed that low-level mosaicism may occur and
this may not be consistantly detected by karyotyping
alone. Seven patients showed normal results by karyo-
typing but by interphase FISH additional cell line of
aneuploid cells were detected. Among these patients, six
revealed low-level sex chromosome mosaicism, in whichTable 2 Discrepancy between karyotype and FISH results
Karyotype FISH [no. of cells]
46,XX nuc ish (DXZ1x1)//(DXZ1x2)*
46,XY nuc ish (DXZ1x1)[77]//(DXZ1,DYZ3)x1[123]
mos 45,X/46,XY nuc ish (DXZ1x1)[299]//(DXZ1,DYZ3)x1[65]//(DXZ
46,X,idic(X)(p22.2) mos 46,X,idic(X)(p22.2).ish idic(X)(p22.2)(DXZ1+++
45,XX,rob(13;14)(q10;q10) nuc ish (D18Z1x2)[114]//(D18Z1x1)[31]//(D18Z1x
*Ratio in each patient is shown in Table 4.2 of them (case no. 09 PB279 and 09 PB439) showed the
presence of monosomy X of less than 10% and 4 (case
no. 09 PB422, 09 PB432, 09 PB447, and 09 PB453)
showed less than 6% (Table 4). The presence of addi-
tional monosomy X cell line, although it is at low level,
could be responsible in growth retardation disease. On
the other hand, metaphase FISH analysis was carried out
in a nonmosaic 46,X,idic(X)(p22.2) patient to confirm
isodisentric and the result revealed mosaic idic(X)/XX,
of which out of 100 cells analyzed 94 cells (94%) were









Figure 1 Partial G-Banded karyotype of chromosome 18. On the
left, is shown the normal chromosome 18; on the right, an
additional segment replacing 18p.
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X/46,XY karyotyped patient (Table 2) showed additional
XYY cell line (9%) with monosomy X cell line being the
most prevalent (74.8%).
The loss of aneuploid cells during cell culture process
is considered as the limitation of karyotyping in detect-
ing low level mosaicism. Interphase FISH technique uses
uncultured cells thus the chance of finding aneuploid
cells is higher. Van Dyke et al. [18] stated that FISH
method is sensitive and specific, and can be employed9 r(9)(p24q34)
Figure 2 Partial G-Banded karyotype of chromosome 9. On the
left, is shown the normal chromosome 9; on the right, is the ring
chromosome 9.on the same blood sample that is used for the conven-
tional cytogenetic studies.
Wolff et al. [16] mentioned that the detection of a low
level of 45,X cells (<10%) during routine cytogenetic
analysis of peripheral blood or bone marrow from an
adult female can be difficult to interpret. Our patients
were in the range of preteens to teenagers (mean age
10.7 years old). According to Russell et al. [24] study the
frequency of X chromosome loss at age < 16 years is very
low (0.07%), thus the low level of monosomy X in our
prepubertal age patients were consistent with Turner
syndrome and were not due to age-related X chromo-
some loss.
In our study interphase FISH analysis were carried out
in up to 200 to 300 cells, these large numbers of cells
should be sufficient in detecting low-level mosaicsim, as
Wiktor et al. [17] suggested that interphase FISH ana-
lysis of 200 cells provides a confidence level of 95% at
detecting a cell line occurring at 2%.
The discordances between karyotyping and FISH
results indicate that FISH analysis should be performed
routinely on short stature patients as an adjunct to
karyotyping, and metaphase FISH analysis need to be
done when patients reveal nonmosaic structural abnor-
malities of X chromosome to exclude mosaicism. Inter-
phase FISH, however, is a more accurate technique to
see ratio of mosaicism than metaphase FISH.
Patients with structural sex chromosome abnormality
are mostly tend to be mosaic with 45,X cell line due
to the loss of the abnormal chromosome during mi-
tosis [25]. These structurally abnormal sex chromo-
somes are preferentially inactivated and tend to be lost
during subsequent mitotic cell divisions, as shown in
long term cultivation experiments, and this finding
suggest that the same mechanism also occur in vivo
[26]. This mechanism is applied not just for isochro-
mosomes and isodicentric but also for other structural
abnormalities such as ring Y and deletion of Xp. This
mitotic loss of structurally abnormal sex chromosome
may results in the relatively high frequency of mosai-
cism. This phenomenon was seen in our patients with
mosaic isochromosome Xq (45,X/46,X,i(Xq)), which
occurred in 8.25% out of 97 patients (2 patients in
group A and 6 patients in group B) and was the most
frequent structural abnormality found in our series.
The possible mechanism for X/XY/XYY mosaicism is
due to post-zygotic mitotic error, which might occur
after the first mitosis (Post first cell division nondisjunc-
tion). The possible explanation for the low percentage of
XY population (16.2%) is there may be further non-
disjunction occurred in some of the XY cells resulting in
X/XYY cell lines hence lowered the XY cell population
and increased the number of cells with monosomy X





Figure 3 Partial G-banded karyotype of chromosome 11. On
the left, is shown the normal chromosome 11; on the right, an
additional segment attached to band q24 of chromosome 11.
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may due to further nondisjunction in XYY or structural
abnormalities in one of the Y chromosomes resulting in
mitotic instablity. Bulakbasi et al. [27] study reported a
Yq microdeletion found in a mos 45.X/46,XY karyotyped
patient with mos 45,X/47,XYY/46,XY karyotype from
testicular tissue cultures may induce mitotic instability
of the Y chromosome and cause mosaicism that may be
undetected in blood cells but make considerable contri-
bution to the germinal tissue. Yq microdeletion can be
detected using multiplex PCR. Thus we suggest a more
sensitive method such as multiplex PCR to discover the
mechanism.
Chromosome analysis using both methods showed
normal results in three patients diagnosed with short
stature (one of them was also diagnosed with dys-
morphism). This indicated that the short stature in
these patients might be due to other causes rather thanTable 3 Short stature patients with autosomal chromosome s
Case no. Age (yrs) Clinical data Karyoty
05 PB25 12 SS 45,XX,rob
(q10;q10
05 PB53 3 SS, microcephaly, FTT,
dismorphic face
mos 46,X
05 PB73 12 SS, no menstruation —
09 PB42 5 SS, cubitus valgus, clinodactily mos 45,X
(p24q34
09 PB443 5 SS, dysmorphism 46,XY,ad
SS short stature; FTT failure to thrive.chromosomal defect, such as Noonan syndrome, hypo-
thyroidism, celiac disease, lead poisoning, neurofibroma-
tosis, growth hormone deficiency or an underlying
medical condition that was previously undiagnosed [2].
Short stature could also be due to constitutional delay of
growth and could also be familial.
A single gene disorder such as deletion or mutation of
SHOX gene, SHOX (short stature homeobox) could also
result in short stature. SHOX gene mutations were more
common among children with certain anthropometric
and dysmorphic signs [4] and have been detected in
2.4% of children with short stature [20]. However, small
deletions or mutations of SHOX gene cannot be detected
by conventional chromosome analysis. Therefore, further
study to detect SHOX gene mutation is suggested in short
stature patients with normal karyotype and FISH results.
As suggested by ACMG practice guideline [28], for short
stature patients with other anomalies/malformations that
are consistent with recognizable genetic syndrome mo-
lecular genetic testing, including SHOX gene testing,
is required to confirm the condition. If the anomalies/
malformations do not suggest a recognizable syndrome
genomic array studies may be considered to evaluate any
changes of genomic copy number. Molecular genetic evalu-
ation including genomic array studies are required to con-
firm the condition in those without chromosomal defect,
although to most of Indonesian population the cost of such
genetic evaluation is still considered expensive.
Autosomal chromosome abnormalities have also been
known to be associated with short stature [5-13]. In our
study, a normal karyotype patient (Case no. 05 PB25)
was found to have mosaic aneuploidy of chromosome
18, of which 20.7% were monosomy 18, 3,3% were tri-
somy 18 and 76% were normal using interphase FISH
(Table 4), while interphase FISH result of another pa-
tient (Case no. 05 PB73) showed mosaic monosomy 18
(12%) and normal (88%). To lower the incidence of
missed-interpretation of probes and karyotyping, all
FISH and karyotyping analysis were performed by two
certified cytogeneticists. Although, when it is available, atructural abnormalities
ping results [no. of cells] FISH results [no. of cells]








Figure 4 Interphase FISH result showing mosaic monosomy 18. The blue signals represent chromosome 18. Three signals: trisomy 18 (red
arrows); two signals: diploid number of chromosome 18; one signal: monosomy 18.
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ings cannot be ignored and must be confirmed by fur-
ther analysis.
There are several possible mechanisms for mosaic
aneuploidy of chromosome 18. Firstly, due to non-
disjunction that may occur after the first mitosis of
post-zygotic cell division resulting in mosaic with 46
chromosomes (diploid) from the first mitosis and with
45 (monosomy) and 47 chromosomes (trisomy) from
the second mitosis (this might be the mechanism for
Case no. 05 PB25), while anaphase lag is the suggested
mechanism for the formation of mosaicism (mono-
somy and diploid) in Case no. 05 PB73. Secondly, the
presence of ring chromosome 18, which is unstable
and tends to be lost in mitosis, resulting in mosaicFigure 5 Interphase FISH result showing mosaic monosomy 18.
The blue signals represent chromosome 18. Two signals: diploid
number of chromosome 18; one signal: monosomy 18.aneuploidy chromosome 18. Cells with one copy of
the chromosome are more often severely disadvantaged
and usually will not continue to reproduce. This explains
the lower ratio of monosomy population compared to
normal (diploid).
Ring chromosomes are formed due to breakage at both
ends of the p and q arms and the joining back of the
broken ends with loss of terminal regions. Loss of 18q
region has been identified in growth hormone deficiency
(GHD) patients and out of 60 genes contained in this re-
gion, 2 genes have been identified and one of these
genes, the galanin receptor type 1(GALR1) which is a
candidate gene for GHD due to its hypothalamic in-
volvement in growth hormone regulation [5]. GALR1
gene is located in 18q23, which is at the terminal of long
arm of chromosome 18. Maranda et al. [7] revealed 46,
XX,del(18)(p11.2) in patients with short stature, dys-
morphic features and moderate mental retardation. Fur-
ther investigation using FISH with 18p/18q subtelomeric
probes showed a terminal deletion of 18p. Thus terminal
deletion of 18p and 18q is associated with short stature.
The loss of terminal regions in ring chromosome 18 and
the loss of GALR1 gene cause short stature. Clinically,
in this case, hormonal profile is needed to confirm
growth hormone deficiency.
In case no. 05 PB53, an additional segment of unknown
origin replaced the whole p arm of chromosome 18 by
attaching to the centromere. The loss of the whole p
arm of chromosome 18 is associated with short stature,
microcephaly and dysmorphic features [11]. Despite
these clinical findings other dysmorphologies may be
manifested as the consequences of active genes con-
tained in the additional segment. However, the sever-
ity of the clinical features is also determined by the
Figure 6 Total number of cases in each group according to chromsomal abnormalities. P-values shown above each group of histograms
represent the association betwen chromosomal abnormalities and the phenotypes of the patients. A: group of patients with other clinical
features; B: group of patients without other clinical features (short stature only).
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mosaic 46,XX,add(18p)[16%]/46,XX[84%] which is
shown in Table 3.
In the case of additional of unknown segment, paren-
tal karyotyping should be carried out to discover its ori-
gin, as most of such cases are the result of balance
translocation that occurred in one of the parents. Unfor-
tunately, in both of our patients with additional segment
(case no. 05 PB53 and 09 PB438) parental karyotypings
were not carried out. For the case of normal parental
karyotype, structural mosaicism is most likely occured
spontanously during early mitosis of an initially normal
zygote, in which it is relatively a rare incidence [29].
In case no. 09 PB438, an additional segment was
attached to band q24 and replaced the segment q25 and
the terminal region of chromosome 11. 11q terminal de-
letion disorder is also known as Jacobsen syndrome, in
which among other clinical manifestations, also causes
short stature [10,30]. Most children with this syndrome
are reported to have IGF-I (insulin growth factor-I) defi-
ciency [10].
Short stature patients with ring chromosome 9 have
been reported [9,13]. Terminal deletions of 9p and 9q are
associated with growth retardation [9]. The ringTable 4 Discrepancies between FISH and karyotyping
results in short stature patients with nonmosaic 46,XX
karyotyping
Case no. Group Karyotype FISH results[no. of cells]
09 PB279 B 46,XX nuc ish (DXZ1x1)[21]//(DXZ1x2)[229]
09 PB422 B 46,XX nuc ish (DXZ1x1)[16]//(DXZ1x2)[284]
09 PB432 B 46,XX nuc ish (DXZ1x1)[10]//(DXZ1x2)[290]
09 PB447 A 46,XX nuc ish (DXZ1x1)[9]//(DXZ1x2)[291]
09 PB453 A 46,XX nuc ish (DXZ1x1)[15]//(DXZ1x2)[285]
09 PB439 B 46,XX nuc ish (DXZ1x1)[23]//(DXZ1x2)[277]structure is unstable therefore it tends to be eliminated
during mitosis resulting in mosaic 45,XY,-9/46,XY,r(9)
(p24q34).
Besides FISH technique, comparative genomic hybri-
dization or SNP array are now widely used to eliminate
culture bias produced by analysis of metaphase cells by
analyzing DNA extraction from both interphase and
metaphase cells and to detect low-level mosaicism by
simultaneous evaluation of DNA copy number to detect
mosaic gains and losses [31]. Further analysis using this
technique should be performed to confirm patients with
low-level mosaicism and discordant results.
Statistical analysis showed no significant association bet-
ween the groups and the type of chromosomal abnorma-
lities. This finding suggests that short stature patients
without other clinical features could have similar oppor-
tunities of carrying mosaic or other chromosomal abnor-
malities as those with other clinical features. This indicates
chromosome analysis is required for short stature evalu-
ation, especially in patients without clear clinical etiologies.
In conclusions, wide variations of chromosome ab-
berations were found in short stature patients with and
without additional clinical features. Exlcuding nonmo-
saic monosomy X, our study showed chromosome ab-
normalities were detected in 48.45% of short stature
patients with and without other clinical features, and the
abnormalities include non-structural sex chromosomes
mosaicism, mosaic and nonmosaic sex chromosomes
structural abnormalities and autosomal structural abnor-
malities. Interphase FISH needs to be routinely per-
formed as an adjunct to karyotyping to detect low-level
mosaicsm in short stature patients. Although it is rare,
autosomal chromosome abnormalities which mostly in-
volving terminal regions of certain chromosomes, can be
responsible for growth failure. Thus subtelomeric FISH
is suggested to be carried out in such cases. However, it
Figure 7 Metaphase FISH result showing mosaic idic(X)/XX. (A) shows two green signals in one of the X chromosomes represent idic(X)
(p22.2), one green signal represent the normal X chromosome; (B) shows one green signal in each of the X chromosome represent the normal X
chromosome (46,XX).
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as one of the most recent technologies for genetic evalu-
ation, is a more sensitive method and can easily detect
subtelomeric deletions and mosaicism.
So far no data of short stature patients in Indonesian
population has been established based on cytogenetic
findings. This study provides recent data of chromo-




The subjects in this study were short stature patients
(less than 3rd percentile) and short stature with other
clinical features. The patients were referred by clinicians all
over Indonesia to Cytogenetics laboratory at the Eijkman
Institute during the year 2003–2009.
Karyotyping
Standard Karyotyping analysis was performed, using
metaphase chromosome preparations from phytohemag-
glutinin stimulated blood lymphocytes of the peripheral
blood [32]. The metaphases were stained using G-
banding technique [33]. Following metaphase staining
chromosome analysis were carried out. For each patient
a total of 20 metaphases were analyzed, in which 15
metaphases were counted and 5 were counted and struc-
turally analyzed. When mosaicism present a total of 40
metaphases were analyzed, in which 35 metaphases were
counted and 5 were counted and structurally analyzed.
The analysis and nomenclature of the chromosomes
were based on ISCN 2009 (An International System for
Human Cytogenetic Nomenclature (2009) [34].
Fluorescence In Situ Hihybridization (FISH)
Standard interphase fluorescence in situ hybridization tech-
nique were applied on uncultured cells to confirm the ratioof mosaicism, using CEP X SpectrumGreen/ CEP Y
SpectrumOrange (Vysis) dual colour probe specific to
the centromere of human chromosome X (bands Xp11.1-
q11.1, locus DXZ1) and to the centromere of human
chromosome Y (bands Yp11.1-q11.1, locus DYZ3),
respectively. Metaphase FISH was carried out to confirm
structurally abnormal sex chromosomes. Chromosome 18
interphase FISH was carried out using CEP 18 SpectrumA-
qua (Vysis), which specific to the centromere of human
chromosome 18 (band region 18p11.1-q11.1, locus D18Z1).
The post-hybridized interphase and metaphase were
counterstained with 125 ng/ml DAPI II suspended in an
antifade solution (Abott Molecular Inc.). A minimum of
50 post-hybridization interphases or metaphases were
analyzed using Nikon eclipse 80i microscope with D-FL
Epi-Fluorescence attachment. The images were captured
by Nikon DS Cooled camera and examined using NIS
Elements Basic Research imaging software. 50 inter-
phases or metaphases were analyzed but for those where
mosaicism present up to 300 interphases or metaphases
were analyzed.
To lower the incidence of missed-interpretation of
probe signals and karyotyping, all FISH and karyoty-
ping analysis were confirmed by at least two certified
cytogeneticists.
Statistical analysis
Statistical analysis was carried out to determine the asso-
ciation between the groups and the type of chromosomal
abnormalities. It was performed by Fisher Exact test and
P-values of less than 0.05 was considered significant.
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